Given a potential role for FOXP1 in development of bone osteoclasts[27] and expression of FOXP2 in bone-resident myeloma cells (in which the bone niche has an essential role in disease pathogenesis and resistance to therapy),[11] we considered whether FOXP2 might play an important role in bone biology. This evidence concerns the gene FOXP2 and plasma cell myeloma.